Kazakh scientists develop nanoparticles for targeted chemo delivery

AI digestMimile.ai EditorialJuly 18, 2026 at 05:46 PM

This digest was compiled by AI from multiple sources — links to the originals are below.

Researchers in Kazakhstan have developed nanoparticles that deliver chemotherapy drugs directly to cancer cells, reducing side effects. The technology, tested in vitro, showed a 30% increase in drug accumulation at tumor sites compared to conventional methods.

The Nanoparticle Design

The nanoparticles, developed by a team at the Institute of Nuclear Physics in Almaty, are coated with a polymer that binds to receptors overexpressed on cancer cells. This allows the particles to release the drug only inside the tumor microenvironment, sparing healthy tissue. The study, published in the journal Nanomedicine, reports a 50% reduction in systemic toxicity in lab tests.

Clinical Potential and Next Steps

The researchers plan to begin animal trials within six months, pending approval from the Ministry of Health. If successful, human clinical trials could start in 2028. The team is also exploring the use of the nanoparticles for delivering other therapies, such as gene-editing tools.

What's Next

The team will seek funding for animal trials from the Science Committee of the Ministry of Education and Science. It remains unclear whether the technology will scale to industrial production or face regulatory hurdles.

1 source

Kazakh scientists develop nanoparticles for targeted chemo delivery

news.google.com

El.kz

New 2D material stacking technique promises quantum computing advance

Scientists from the University of Southampton and the National University of Singapore have developed a fabrication technique for ultra-clean 2D heterostructures. The method enables precise stacking of atom-thin materials, potentially accelerating quantum computing and electronics research.

Mussel protein nanoparticles target pancreatic cancer cells

South Korean researchers developed smart nanoparticles from mussel proteins that remain inert in healthy tissue but activate and release anticancer drugs upon reaching tumor tissue. The technology aims to reduce side effects and improve treatment efficacy for pancreatic cancer, one of the deadliest cancers.

Science

Light-driven method overrides redox limits in molecular synthesis

A new study accepted by Nature describes a light-driven technique that overrides redox potential limits in single-electron transfer reactions. The method uses ultra-powerful photoreductants to reduce competing molecules at nearly equal rates, enabling synthesis of complex ring structures from hard-to-reduce ketones.

Politics

New immunotherapy mechanism targets aggressive brain tumors

Scientists have identified a novel immunotherapy mechanism that targets aggressive brain tumors. The discovery could lead to new treatment approaches for glioblastoma and other hard-to-treat cancers. The findings were published in a peer-reviewed journal.

Kazakh scientists develop nanoparticles for targeted chemo delivery

The Nanoparticle Design

Clinical Potential and Next Steps

What's Next

Read more

Read more